These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [Alpha 1-antitrypsin deficiency and the liver (author's transl)]. Spech HJ, Liehr H. Z Gastroenterol; 1982 Jul; 20(7):393-404. PubMed ID: 6287750 [Abstract] [Full Text] [Related]
10. [Hepatocellular carcinoma and the alpha 1-antitrypsin phenotype]. Labadie H, Sesboué R, Martin JP, Beaugrand M. Gastroenterol Clin Biol; 1985 Dec; 9(12):881-5. PubMed ID: 3007258 [Abstract] [Full Text] [Related]
11. Lack of increase in heterozygous alpha 1-antitrypsin deficiency phenotypes among patients with hepatocellular and bile duct carcinoma. Rabinovitz M, Gavaler JS, Kelly RH, Prieto M, Van Thiel DH. Hepatology; 1992 Mar; 15(3):407-10. PubMed ID: 1312055 [Abstract] [Full Text] [Related]
14. [Primary liver cell carcinoma as complication of alpha 1-antitrypsin deficiency in a 67 year old man]. van den Hazel SJ, Meijer JW, van den Elshout FJ, de Vries RA. Ned Tijdschr Geneeskd; 2000 Nov 18; 144(47):2269-72. PubMed ID: 11109473 [Abstract] [Full Text] [Related]
17. [Focus on a new assay of fucosylated alpha-fetoprotein and evaluation in the biological diagnosis of hepatocellular carcinoma in cirrhosis]. Denis I, Beaudonnet A, Pichot J, Roubille M, Gelineau M. Ann Biol Clin (Paris); 2000 Nov 18; 58(1):85-90. PubMed ID: 10673618 [No Abstract] [Full Text] [Related]